segment

Paraquat Farmworker Exposure

Preparing your case review…
Written By
People's Justice Legal Research Team

Farmworkers: The Front Line of Paraquat Exposure

Agricultural workers and farmworkers face the highest levels of paraquat exposure in the United States. Unlike certified applicators, who at least receive training in pesticide handling (however inadequate), many farmworkers enter treated fields with little or no knowledge of the chemicals that have been applied. They may work in fields where paraquat was recently sprayed, handle crops that carry pesticide residue, and breathe air carrying paraquat drift — all without appropriate protective equipment or safety information.

The demographics of the affected workforce are striking. Approximately 96% of California’s farmworkers are Latino, and similar demographic patterns exist across the agricultural states of the Southwest, Southeast, and Midwest. Language barriers, immigration status concerns, economic vulnerability, and limited access to healthcare create compounding obstacles to both medical treatment and legal action. The paraquat litigation specifically addresses the failure of manufacturers to provide adequate safety information in languages spoken by the workers most exposed to the product.

Exposure pathways for farmworkers include dermal absorption from direct skin contact with paraquat-treated plants and soil, inhalation of paraquat mist and dust during field operations, ingestion of contaminated food or water, and contact with paraquat-contaminated tools and equipment. Many farmworkers were never provided with or required to use appropriate personal protective equipment, including chemical-resistant gloves, coveralls, and respiratory protection.

Farmworker Legal Rights and Resources

Farmworkers have the same legal rights as any other plaintiff in the paraquat litigation, regardless of immigration status. Attorney-client privilege protects all communications between farmworkers and their lawyers. The litigation targets the paraquat manufacturers and distributors — Syngenta, Chevron Phillips Chemical, and Growmark — not the farms or agricultural employers (although separate workers’ compensation claims may also apply).

Spanish-speaking legal services are available through many firms involved in the paraquat MDL, and legal aid organizations in agricultural regions can provide referrals. The contingency fee structure means farmworkers pay nothing upfront and owe nothing if their case is unsuccessful. Employment records, pay stubs, tax returns, and testimony from co-workers can document agricultural work history even when formal records are incomplete.

Research & Evidence

Scientific Evidence

cross-sectional

Paraquat and Parkinson’s Disease: The Role of Corporate Agnotology

Dorsey ER, et al. (2023). Movement Disorders

Key Findings

  • Syngenta’s corporate predecessor ICI identified paraquat neurotoxicity in 1958 and confirmed brain penetration in 1966
  • The Louise Marks studies documenting substantia nigra cell loss in paraquat-exposed animals were suppressed and not reported to regulators
  • Syngenta’s 2003 "Scientific Influencing Strategy" was a coordinated effort to selectively publish favorable research while discrediting independent scientists
  • Syngenta specifically targeted Dr. Deborah Cory-Slechta and hired v-Fluence to manage reputation and influence scientific discourse
  • The pattern mirrors tobacco industry agnotology documented by Proctor and others, representing a deliberate corporate strategy to maintain a profitable product at the expense of public health
meta-analysis

Exposure to Pesticides or Solvents and Risk of Parkinson Disease (Meta-Analysis)

Pezzoli G, Cereda E. (2013). Neurology

Key Findings

  • Paraquat exposure was associated with an overall odds ratio of 1.64 for Parkinson’s disease, confirming a statistically significant increased risk
  • The association was consistent across multiple independent studies conducted in different countries and populations
  • Herbicide and pesticide exposure in general was associated with a pooled odds ratio of 1.62 for Parkinson’s disease
  • The meta-analytic approach provides the aggregated statistical power that individual studies cannot achieve, strengthening the causal inference
cohort

Rotenone, Paraquat, and Parkinson’s Disease (FAME Study)

Tanner CM, Kamel F, Ross GW, et al. (2011). Environmental Health Perspectives

Key Findings

  • Paraquat users had a 2.5-fold (250%) increased risk of Parkinson’s disease compared to non-users
  • The association was statistically significant and persisted after controlling for confounding variables including age, sex, smoking, and other pesticide exposures
  • Rotenone use was also associated with increased Parkinson’s risk (2.5x), and both compounds inhibit mitochondrial complex I through similar mechanisms
  • The study used objective pesticide application records rather than self-reported exposure, substantially reducing recall bias
FAQ

Frequently Asked Questions

See details below.
See details below.
See details below.
See details below.
See details below.
See details below.
See details below.
See details below.
See details below.
See details below.
See details below.
See details below.
See details below.
See details below.
See details below.
See details below.
See details below.
See details below.
See details below.
See details below.
See details below.
See details below.
See details below.
See details below.
See details below.
See details below.
See details below.
See details below.
See details below.
See details below.
See details below.
See details below.
See details below.
See details below.
See details below.
See details below.
Related Topics

Related Pages

Paraquat Aerial Spray Drift

Aerial application of paraquat produces spray drift that can carry the herbicide hundreds of meters or more from the target area, exposing rural residents, schoolchildren, and bystanders who never directly handled the chemical. Drift exposure is a recognized pathway in the paraquat litigation, and individuals who lived near aerial paraquat operations and developed Parkinson’s disease may have viable claims.

spray-driftaerial-applicationcrop-dusting
Learn more

Paraquat & Early-Onset Parkinson’s

Early-onset Parkinson’s disease (diagnosed before age 50) is more strongly associated with environmental exposures like paraquat than late-onset cases. Individuals who developed Parkinson’s at a younger age after paraquat exposure may have particularly strong claims because early onset is a marker of environmental causation rather than normal aging.

early-onsetyoung-onsetparkinsons
Learn more

Paraquat EPA Ban

Despite more than 70 countries banning paraquat and overwhelming scientific evidence linking it to Parkinson’s disease, the U.S. Environmental Protection Agency has repeatedly declined to ban the herbicide. The EPA’s 2024 registration review reaffirmed paraquat’s approval despite 90 studies submitted by the Michael J. Fox Foundation. This regulatory failure is cited in the litigation as evidence that judicial remedies are necessary to protect American farmworkers and rural communities.

epabanregulation
Learn more

Paraquat Parkinson’s Disease Lawsuit

Paraquat exposure causes Parkinson’s disease through a well-characterized mechanism of oxidative stress, mitochondrial dysfunction, and selective dopaminergic neuron death. The FAME study found a 2.5x increased risk, and MDL 3004 encompasses approximately 5,000 cases seeking compensation for individuals diagnosed with Parkinson’s after paraquat exposure.

parkinsonslawsuitparaquat
Learn more

Paraquat Settlement Amounts

Paraquat Parkinson’s settlement amounts are projected to range from $20,000 for early-stage cases to over $1,000,000 for severe, long-duration cases with strong exposure documentation. The MDL framework settlement agreement reached in April 2025 provides the structure for individual case resolution. Average projected settlements are $600,000 to $900,000. Filing now positions your claim for the current settlement distribution cycle.

settlementcompensationdamages
Learn more

Syngenta Paraquat Lawsuit

Syngenta is the primary defendant in the paraquat Parkinson’s litigation. The company, formed in 2000 from the merger of ICI/Zeneca and Novartis crop sciences, inherited decades of internal research documenting paraquat’s neurotoxicity. Syngenta implemented a "Scientific Influencing Strategy" to suppress and discredit this evidence. Acquired by ChemChina for $43 billion in 2017, Syngenta has paid $187.5 million in initial settlements and agreed to a broader framework settlement in April 2025.

syngentaicizeneca
Learn more

Paraquat Wrongful Death Claims

Surviving family members can file wrongful death claims on behalf of loved ones who died from Parkinson’s disease caused by paraquat exposure. Parkinson’s is a progressive and ultimately fatal disease, and many paraquat-exposed individuals have already passed away. Wrongful death claims seek compensation for medical costs before death, funeral expenses, lost financial support, and loss of companionship.

wrongful-deathsurvival-actionfamily-claims
Learn more
Parent Case

Paraquat Parkinson’s Lawsuit

Paraquat is a restricted-use herbicide manufactured primarily by Syngenta and distributed by Chevron Phillips Chemical and Growmark. Despite being banned in more than 70 countries including the European Union, China, Brazil, and Thailand, paraquat remains legal in the United States, where approximately 10 million pounds are applied annually. Scientific evidence — including the landmark Farming and Movement Evaluation (FAME) study published in 2011 — demonstrates that paraquat exposure increases the risk of Parkinson’s disease by 2.5 times. The mechanism is well understood: paraquat triggers oxidative stress through redox cycling, inhibits mitochondrial complex I, and selectively kills dopamine-producing neurons in the substantia nigra, leading to the progressive motor and cognitive deterioration characteristic of Parkinson’s disease. MDL 3004 was established in June 2021 in the Southern District of Illinois, with approximately 5,000 cases pending. Bellwether proceedings and settlement negotiations are ongoing, with projected individual settlements ranging from $20,000 to over $1,000,000 depending on disease severity and exposure documentation.

View full case overview